U.S. AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Component
                       1.2.2. Cancer Type
                       1.2.3. Application
                       1.2.4. End-use
                       1.2.5. Country scope
                       1.2.6. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in U.S.
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Component outlook
                       2.2.2. Cancer type outlook
                       2.2.3. Application outlook
                       2.2.4. End-use outlook
                   2.3. Competitive Insights
Chapter 3. U.S. AI in Oncology Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increasing demand for early detection and classification of cancer
                               3.2.1.1.1. Case study 1
                               3.2.1.1.2. Case study 2
                           3.2.1.2. Increasing prevalence of cancer
                               3.2.1.2.1. Breast
                               3.2.1.2.2. Barain & CNS
                               3.2.1.2.3. Kidney
                               3.2.1.2.4. Non-Hodgkin lymphoma
                               3.2.1.2.5. Bladder
                               3.2.1.2.6. Colon & rectum
                               3.2.1.2.7. Prostate
                               3.2.1.2.8. Case Study 3
                           3.2.1.3. Rising adoption of precision medicine
                       3.2.2. Market restraint analysis
                           3.2.2.1. High procurement and implementation cost
                           3.2.2.2. Lack of skilled workforce
                   3.3. U.S. AI in Oncology Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                       3.3.2. PESTEL Analysis
                   3.4. Regulatory Framework
                   3.5. Impact of COVID-19
Chapter 4. U.S. AI in Oncology Market: Component Estimates & Trend Analysis
                   4.1. Component Market Share, 2023 & 2030
                   4.2. Segment Dashboard
                   4.3. U.S. AI in Oncology Market by Component Outlook
                   4.4. Hardware
                       4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   4.5. Software solutions
                       4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   4.6. Services
                       4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. AI in Oncology Market: Cancer Type Estimates & Trend Analysis
                   5.1. Cancer Type Market Share, 2023 & 2030
                   5.2. Segment Dashboard
                   5.3. U.S. AI in Oncology Market by Cancer Type Outlook
                   5.4. Breast Cancer
                       5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   5.5. Lung Cancer
                       5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   5.6. Prostate Cancer
                       5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   5.7. Colorectal Cancer
                       5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   5.8. Brain Tumor
                       5.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   5.9. Others
                       5.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. AI in Oncology Market: Application Estimates & Trend Analysis
                   6.1. Application Market Share, 2023 & 2030
                   6.2. Segment Dashboard
                   6.3. U.S. AI in Oncology Market by Application Outlook
                   6.4. Diagnostics
                       6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   6.5. Radiation Therapy
                       6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   6.6. Research & Development
                       6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   6.7. Chemotherapy
                       6.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   6.8. Immunotherapy
                       6.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. AI in Oncology Market: End-use Estimates & Trend Analysis
                   7.1. End-use Market Share, 2023 & 2030
                   7.2. Segment Dashboard
                   7.3. U.S. AI in Oncology Market by End-use Outlook
                   7.4. Hospitals
                       7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   7.5. Surgical Centers & Medical Institutes
                       7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                   7.6. Others
                       7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                   8.3. Vendor Landscape
                       8.3.1. List of key distributors and channel partners
                       8.3.2. Key customers
                       8.3.3. Key company market share analysis, 2023
                   8.4. Company Profiles
                       8.4.1. Azra AI
                           8.4.1.1. Company overview
                           8.4.1.2. Financial performance
                           8.4.1.3. Product benchmarking
                           8.4.1.4. Strategic initiatives
                       8.4.2. iCAD, Inc.
                           8.4.2.1. Company overview
                           8.4.2.2. Financial performance
                           8.4.2.3. Product benchmarking
                           8.4.2.4. Strategic initiatives
                       8.4.3. IBM
                           8.4.3.1. Company overview
                           8.4.3.2. Financial performance
                           8.4.3.3. Product benchmarking
                           8.4.3.4. Strategic initiatives
                       8.4.4. Siemens Healthcare GmbH
                           8.4.4.1. Company overview
                           8.4.4.2. Financial performance
                           8.4.4.3. Product benchmarking
                           8.4.4.4. Strategic initiatives
                       8.4.5. Intel Corporation
                           8.4.5.1. Company overview
                           8.4.5.2. Financial performance
                           8.4.5.3. Product benchmarking
                           8.4.5.4. Strategic initiatives
                       8.4.6. GE HealthCare
                           8.4.6.1. Company overview
                           8.4.6.2. Financial performance
                           8.4.6.3. Product benchmarking
                           8.4.6.4. Strategic initiatives
                       8.4.7. NVIDIA Corporation
                           8.4.7.1. Company overview
                           8.4.7.2. Financial performance
                           8.4.7.3. Product benchmarking
                           8.4.7.4. Strategic initiatives
                       8.4.8. Digital Diagnostics Inc.
                           8.4.8.1. Company overview
                           8.4.8.2. Financial performance
                           8.4.8.3. Product benchmarking
                           8.4.8.4. Strategic initiatives
                       8.4.9. ConcertAI
                           8.4.9.1. Company overview
                           8.4.9.2. Financial performance
                           8.4.9.3. Product benchmarking
                           8.4.9.4. Strategic initiatives
                       8.4.10. Median Technologies
                           8.4.10.1. Company overview
                           8.4.10.2. Financial performance
                           8.4.10.3. Product benchmarking
                           8.4.10.4. Strategic initiatives
                       8.4.11. PathAI
                           8.4.11.1. Company overview
                           8.4.11.2. Financial performance
                           8.4.11.3. Product benchmarking
                           8.4.11.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 3 U.S. AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 4 U.S. AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. AI in oncology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in U.S.
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. AI in oncology market: market outlook
Fig. 10 U.S. AI in oncology competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. AI in oncology market driver impact
Fig. 16 U.S. AI in oncology market restraint impact
Fig. 17 U.S. AI in oncology market strategic initiatives analysis
Fig. 18 U.S. AI in oncology market: Component movement analysis
Fig. 19 U.S. AI in oncology market: Component outlook and key takeaways
Fig. 20 Hardware market estimates and forecast, 2018 - 2030
Fig. 21 Software market solutions estimates and forecast, 2018 - 2030
Fig. 22 Services market estimates and forecast, 2018 - 2030
Fig. 23 U.S. AI in oncology market: Cancer type movement Analysis
Fig. 24 U.S. AI in oncology market: Cancer type outlook and key takeaways
Fig. 25 Breast cancer market estimates and forecasts, 2018 - 2030
Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030
Fig. 27 Prostate cancer market estimates and forecasts, 2018 - 2030
Fig. 28 Colorectal cancer market estimates and forecasts, 2018 - 2030
Fig. 29 Brain Tumor market estimates and forecasts, 2018 - 2030
Fig. 30 Others market estimates and forecasts, 2018 - 2030
Fig. 31 U.S. AI in oncology market: application movement analysis
Fig. 32 U.S. AI in oncology market: application outlook and key takeaways
Fig. 33 Diagnostics market estimates and forecasts, 2018 - 2030
Fig. 34 Radiation therapy market estimates and forecasts, 2018 - 2030
Fig. 35 Research & development market estimates and forecasts, 2018 - 2030
Fig. 36 Chemotherapy market estimates and forecasts, 2018 - 2030
Fig. 37 Immunotherapy market estimates and forecasts, 2018 - 2030
Fig. 38 U.S. AI in oncology market: end-use movement analysis
Fig. 39 U.S. AI in oncology market: end-use outlook and key takeaways
Fig. 40 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 41 Surgical centers & medical institutes market estimates and forecasts, 2018 - 2030
Fig. 42 Others market estimates and forecasts, 2018 - 2030
Fig. 43 U.S. AI in oncology market share and leading players
Fig. 44 U.S. market share and leading players
Fig. 45 Market share of key market players - U.S. AI in Oncology market